Publication | Closed Access

Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis

HemodialysisHeart FailureRadiologyCardiorenal SyndromesCardiovascular DiseaseRenal FunctionMedicineKidney FailureMyocardial PerfusionPharmacologic Stress AgentCardiologyPublic HealthChronic Kidney DiseaseAtherosclerosisNephrologyAnesthesiologyCardiovascular Imaging